PLUS THERAPEUTICS (PSTV) director files Form 3 with zero shares

Rhea-AI Filing Summary

PLUS THERAPEUTICS, INC. director Ronald Asbury Andrews filed an initial Form 3 reporting his beneficial ownership in the company. The filing shows he directly holds 0 shares of Common Stock as of the reported date, establishing a baseline ownership position for future insider reports.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider ANDREWS RONALD ASBURY

Role Director

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 0 shares (Direct)

Footnotes (1)

Key Figures

Shares following reported position: 0.0000 shares Insider role: Director Security title: Common Stock

3 metrics

Shares following reported position 0.0000 shares Total Common Stock directly owned after reported position

Insider role Director Reporting person role at PLUS THERAPEUTICS, INC.

Security title Common Stock Class of securities reported in Form 3

Key Terms

Form 3, Common Stock, beneficial ownership, direct ownership

4 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3): initial statement of beneficial ownership"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

Common Stock financial

"security_title: Common Stock reported for PLUS THERAPEUTICS, INC."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

beneficial ownership financial

"Form 3 serves as the initial statement of beneficial ownership"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

direct ownership financial

"ownership_type: direct with 0.0000 total shares following transaction"

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

ANDREWS RONALD ASBURY

(Last) (First) (Middle)

6420 LEVIT GREEN BOULEVARD

SUITE 310

(Street)

HOUSTON TEXAS 77021

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/20/2026

3. Issuer Name and Ticker or Trading Symbol
PLUS THERAPEUTICS, INC. [ PSTV ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Andrew Sims, attorney-in-fact	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Ronald Asbury Andrews’ Form 3 for PSTV report?

The Form 3 for PLUS THERAPEUTICS, INC. (PSTV) reports director Ronald Asbury Andrews’ initial beneficial ownership. It shows he directly holds 0 shares of Common Stock, creating a baseline for any future insider trading disclosures.

Does Ronald Asbury Andrews own PLUS THERAPEUTICS (PSTV) common stock according to this Form 3?

According to this Form 3, director Ronald Asbury Andrews directly owns 0 shares of Common Stock. This reflects his reported beneficial ownership at the time of filing and will serve as the reference point for later Form 4 or Form 5 updates.

Is there any buy or sell transaction disclosed in this PSTV Form 3?

No buy or sell transaction is disclosed. The data classifies the entry as a holding with an unknown transaction code and shows 0 shares following the reported position, consistent with a baseline ownership statement rather than a trade.

What security is covered in Ronald Asbury Andrews’ Form 3 for PLUS THERAPEUTICS?

The Form 3 covers Common Stock of PLUS THERAPEUTICS, INC.. It shows a direct ownership type with 0.0000 total shares following the reported position, indicating no directly held common shares at that time.

How many PLUS THERAPEUTICS (PSTV) shares does the Form 3 show after the reported position?

The Form 3 shows 0.0000 total shares of Common Stock following the reported position for director Ronald Asbury Andrews. This zero balance defines his starting reported stake for future insider ownership and transaction filings.